Document Detail


Vascular Response to Zotarolimus-Coated Balloons in Injured Superficial Femoral Arteries of the Familial Hypercholesterolemic Swine.
MedLine Citation:
PMID:  21953371     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: =0.007; low-dose ZCB 22% reduction, P=0.08). There was no evidence of delayed arterial healing or vascular toxicity in any of the ZCB groups.Conclusions-The single delivery of zotarolimus via coated balloon is feasible, and therapeutic levels are maintained up to 28 days. The ZCB technology appears to be effective in the reduction of neointimal proliferation in the superficial femoral artery of the familial hypercholesterolemic swine.
Authors:
Juan F Granada; Krzysztof Milewski; Hugh Zhao; John J Stankus; Armando Tellez; Michael S Aboodi; Greg L Kaluza; Christian G Krueger; Renu Virmani; Lewis B Schwartz; Alexander Nikanorov
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-9-27
Journal Detail:
Title:  Circulation. Cardiovascular interventions     Volume:  -     ISSN:  1941-7632     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-9-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101499602     Medline TA:  Circ Cardiovasc Interv     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation, Orangeburg, NY; Abbott Vascular, Santa Clara, CA; Department of Animal Sciences, University of Wisconsin, Madison WI; and CVPath Institute, Inc, Gaithersburg, MD.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropop...
Next Document:  Ranolazine Injection Into Coronary or Femoral Arteries Exerts Marked, Transient Regional Vasodilatio...